An Observational Retrospective Study to Evaluate Treatment Patterns of Botulinum Toxin Type A

Allergan

Status: Completed

Conditions: Facial Rhytides

Treatments: Drug: botulinum toxin Type A

Study type: Observational

Funder types: Industry

Identifiers

NCT01608659

GMA-BTXC-10-001

Details and patient eligibility

About

This is a retrospective chart review to evaluate treatment patterns of botulinum toxin Type A for the treatment of facial lines.

Enrollment: 110 patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Previously treated for glabellar lines (hyperfunctional facial lines) with botulinum toxin Type A preparation
• Received 2 treatment cycles wtih botulinum toxin Type A (BOTOX®) prior to at least 1 treatment with botulinum toxin Type A (Xeomin®)

Exclusion criteria

• None

Trial design

110 participants in 1 patient group

botulinum toxin Type A

Description:

Previous treatment with botulinum toxin Type A for treatment of facial lines

Treatment:

Drug: botulinum toxin Type A